Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

386
Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
386
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

287
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
287
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

223
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
223
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

221
Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
221
Hypersensitivities01:30

Hypersensitivities

7.3K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.3K
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

232
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
232

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Septic arthritis of the pubic symphysis: an atypical abdominal pain.

Acta clinica Belgica·2014
Same author

Guillain-Barré syndrome associated with Puumula Hantavirus infection.

Acta clinica Belgica·2014
Same author

Intraperitoneal meropenem administration: a possible alternative to the intravenous route.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2010
Same author

Group C streptococcal psoas abscess associated with a homolateral hip joint prosthesis infection: a case report.

Acta clinica Belgica·2009
Same author

[World kidney Day 2008: the impact of epidemiology of kidney diseases in Belgium].

Revue medicale de Bruxelles·2008
Same author

Severe peritonitis due to Pantoea agglomerans in a CCPD patient.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2008

Related Experiment Video

Updated: May 6, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

9.9K

Azathioprine hypersensitivity syndrome: a case report.

S Fenaux1, M Tintillier, Ch Cuvelier

  • 1Department of Internal Medicine and Nephrology, Clinique et Maternité Sainte Elisabeth, Namur, Belgium. fenauxsarah@hotmail.be

Acta Clinica Belgica
|October 26, 2013
PubMed
Summary

A rare azathioprine hypersensitivity syndrome caused a febrile rash and joint pain in a patient. Stopping azathioprine treatment led to rapid recovery, highlighting its importance in managing this adverse drug reaction.

More Related Videos

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

3.3K
Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
10:22

Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity

Published on: September 16, 2011

35.1K

Related Experiment Videos

Last Updated: May 6, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

9.9K
Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis
08:25

Contact Hypersensitivity as a Murine Model of Allergic Contact Dermatitis

Published on: September 26, 2022

3.3K
Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
10:22

Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity

Published on: September 16, 2011

35.1K

Area of Science:

  • Clinical Medicine
  • Dermatology
  • Pharmacology

Background:

  • Azathioprine is an immunosuppressive drug used in various autoimmune and inflammatory conditions.
  • Hypersensitivity reactions to azathioprine are uncommon but can manifest with diverse clinical symptoms.
  • Understanding the diagnostic criteria and management of azathioprine hypersensitivity is crucial for patient safety.

Observation:

  • A 51-year-old male developed a febrile cutaneous eruption and arthralgia 10 days after initiating azathioprine therapy.
  • Clinical examination revealed no inflammatory syndrome, and all bacteriological tests were negative.
  • Skin biopsy showed granulocytary pustules, dermal edema, and neutrophil infiltration, without vasculitis.

Findings:

  • The clinical presentation and biopsy results were consistent with azathioprine hypersensitivity syndrome.
  • This syndrome is an idiosyncratic, non-IgE-mediated reaction.
  • Diagnosis relies on clinical suspicion and exclusion of other causes.

Implications:

  • Discontinuation of azathioprine is the primary and effective treatment for hypersensitivity syndrome.
  • Prompt recognition and cessation of the offending drug are vital for patient recovery.
  • This case underscores the importance of considering drug-induced hypersensitivity in patients presenting with unexplained febrile eruptions and systemic symptoms.